Trademark: 97005028
Word
ALIN
Status
Pending
Status Code
681
Status Date
Tuesday, May 21, 2024
Serial Number
97005028
Mark Type
4
Filing Date
Tuesday, August 31, 2021
Published for Opposition
Tuesday, June 25, 2024

Trademark Owner History

Classifications
5 Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, endocrinology for treatment of adrenal failure, thyroiditis; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, rheumatology for treatment of rheumatoid arthritis, gout, post-traumatic arthritis, osteoarthritis, synovitis, bursitis, epicondylitis, ankylosing spondylitis, systemic or discoid lupus erythematosus, dermatomyositis, scleroderma, other collagen diseases, other osteoarticular diseases which require chronic corticosteroid administration; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, dermatology for treatment of pemphigus, erythema multiforme, exfoliative dermatitis, psoriasis, contact dermatitis, keloid lesions, hyperthrophic lichen planus, alopecia areata, urticaria, eczema, rosacea; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, allergology for treatment of bronchial asthma, urticaria, drug or food allergy, hypersensitivity reactions, allergic rhinitis, allergic sinusitis; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, otolaryngology for treatment of vasomotor rhinitis, other types of rhinitis; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, ophthalmology for treatment of allergic, acute or chronic conjunctivitis, scleritis, uveitis, iridocyclitis, optic neuritis, corneal infections, keratitis, marginal ulcers, throphic disorders, conjunctival, corneal physical, chemical burning, and inflammatory reactions; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, gastroenterology for treatment of ulcerative colitis, regional enteritis; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, pulmonology for treatment of bronchoaspiration, Löeffler syndrome, sarcoidosis, interstitial pulmonary fibrosis, chronic bronchitis, emphysema; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, hematology for treatment of autoimmune anemias or thrombocytopenias, leukemias, lymphomas, intravascular coagulation syndrome; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, oncology for treatment of nausea and vomiting associated with cancer chemotherapy prevention; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, miscellaneous for treatment of shock syndromes, cerebral edema
The English translation of "ALIN" in the mark is "lowest".

Trademark Events
Sep 3, 2021
New Application Entered
Oct 14, 2021
New Application Office Supplied Data Entered
Jun 4, 2022
Assigned To Examiner
Jun 4, 2022
Non-Final Action Written
Jun 4, 2022
Non-Final Action E-Mailed
Jun 4, 2022
Notification Of Non-Final Action E-Mailed
Nov 30, 2022
Priority Action Written
Nov 30, 2022
Priority Action E-Mailed
Nov 30, 2022
Notification Of Priority Action E-Mailed
May 30, 2023
Teas Response To Office Action Received
May 30, 2023
Correspondence Received In Law Office
May 31, 2023
Teas/Email Correspondence Entered
Jun 1, 2023
Suspension Letter Written
Jun 1, 2023
Letter Of Suspension E-Mailed
Jun 1, 2023
Notification Of Letter Of Suspension E-Mailed
Nov 29, 2023
Notification Of Inquiry As To Suspension E-Mailed
Nov 29, 2023
Suspension Inquiry Written
Nov 29, 2023
Inquiry To Suspension E-Mailed
Dec 11, 2023
Teas Response To Suspension Inquiry Received
May 17, 2024
Approved For Pub - Principal Register
Apr 30, 2024
Teas/Email Correspondence Entered
Apr 30, 2024
Assigned To Lie
Apr 30, 2024
Correspondence Received In Law Office

Trademark Alertz updated from USPTO on 2030-01-24